NARCISS BROWN: Open Payments
NPI 1508232547 · SIMPSONVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,082 in 57 payments from 17 companies in 2025. Trend: 2023 $1,347 · 2024 $998 · 2025 $1,082
Food & beverage: $1,082
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 13 | $248 |
| ABBVIE INC. | 13 | $175 |
| AstraZeneca Pharmaceuticals LP | 4 | $159 |
| Novo Nordisk Inc | 7 | $117 |
| PFIZER INC. | 4 | $78 |
| Abbott Laboratories | 2 | $48 |
| Astellas Pharma US Inc | 2 | $44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| Dexcom, Inc. | 1 | $27 |
Products named: JARDIANCE, MOUNJARO, QULIPTA, BREZTRI, AIRSUPRA, UBRELVY, ELIQUIS, Wegovy.
Industry payments across SC — which companies pay providers there.
